AUTIFONY THERAPEUTICS LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	25
#2	United Kingdom	17
#3	WIPO (World Intellectual Property Organization)	12
#4	EPO (European Patent Office)	10
#5	Brazil	8
#6	China	8
#7	Israel	6
#8	Australia	5
#9	Canada	4
#10	Republic of Korea	4
#11	EAPO (Eurasian Patent Organization)	3
#12	Hong Kong	3
#13	Singapore	3
#14	India	2
#15	Mexico	2
#16	South Africa	2
#17	Japan	1
#18	Taiwan	1

#	Industry
#1	Pharmaceuticals
#2	Organic fine chemistry

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Acyclic or carbocyclic compounds
#5	Special acyclic compounds

Publication	Filing date	Title
AU2019360017A1	2019-10-16	Novel compounds
GB201801508D0	2018-01-30	Novel compounds
GB201801493D0	2018-01-30	Novel compounds
GB201801503D0	2018-01-30	Novel Compounds
GB201801505D0	2018-01-30	Novel compounds
WO2018109484A1	2017-12-15	Hydantoin modulators of kv3 channels
GB201613163D0	2016-07-29	Novel compounds
GB201522179D0	2015-12-16	Novel compounds
GB201521751D0	2015-12-10	Novel uses
GB201421784D0	2014-12-08	Novel compounds
GB201321811D0	2013-12-10	Novel compounds
WO2013182851A1	2013-06-06	Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required
WO2013175215A1	2013-05-22	Triazoles as kv3 inhibitors
EP2852588A1	2013-05-22	Hydantoin derivatives as kv3 inhibitors
GB201222528D0	2012-12-13	Novel uses
GB201222391D0	2012-12-12	Novel Uses
GB201222393D0	2012-12-12	Novel compounds
GB201222385D0	2012-12-12	Novel compunds
MX2014006753A	2012-12-06	Hydantoin derivatives useful as kv3 inhibitors.
WO2012168710A1	2012-06-07	Hydantoin derivates as kv3 inhibitors